Back to Search
JENNIFER ANNE CERUTTI MD
MD
Urology Physician
NPI: 1598976821Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
MD-46011(IA)036115248(IL)
Research & Publications (20)
[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
PMID 17891248·Arq Bras Endocrinol Metabol·2007
6-review
A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
PMID 15085203·J Clin Invest·2004
8-other
Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.
PMID 12952364·J Endocrinol Invest·2003
8-other
What can digital transcript profiling reveal about human cancers?
PMID 12886451·Braz J Med Biol Res·2003
8-other
Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.
PMID 19138318·Clin Endocrinol (Oxf)·2009
8-other
Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
PMID 18727708·Clin Endocrinol (Oxf)·2009
8-other
High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.
PMID 19152441·Cancer·2009
8-other
Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence.
PMID 19146837·Brain Res·2009
7-preclinical
Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
PMID 19169500·Arq Bras Endocrinol Metabol·2008
5-case
Seven-year follow-up of a juvenile female with papillary thyroid carcinoma with poor outcome, BRAF mutation and loss of expression of iodine-metabolizing genes.
PMID 19169486·Arq Bras Endocrinol Metabol·2008
5-case
Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.
PMID 18676742·Clin Cancer Res·2008
8-other
Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.
PMID 18559958·Endocr Relat Cancer·2008
7-preclinical
Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.
PMID 17699795·Cancer Res·2007
8-other
Y791F RET mutation and early onset of medullary thyroid carcinoma in a Brazilian kindred: evaluation of phenotype-modifying effect of germline variants.
PMID 17610518·Clin Endocrinol (Oxf)·2007
5-case
Identification of candidates for tumor-specific alternative splicing in the thyroid.
PMID 16493598·Genes Chromosomes Cancer·2006
8-other
Diagnosis of suspicious thyroid nodules using four protein biomarkers.
PMID 16740752·Clin Cancer Res·2006
8-other
[Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
PMID 16444351·Arq Bras Endocrinol Metabol·2005
6-review
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer.
PMID 15753364·Cancer Res·2005
8-other
Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors.
PMID 15785240·Thyroid·2005
8-other
Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis.
PMID 15807885·Clin Endocrinol (Oxf)·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via UROLOGY, LTD. · 2 locations total
- Address
- 745 FLETCHER DR, SUITE 301
ELGIN, IL 60123 - Phone
- (847) 741-0398
Quick Facts
- NPI
- 1598976821
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile